Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

New Hyde Park, Israel Clinical Trials

A listing of New Hyde Park, Israel clinical trials actively recruiting patients volunteers.

RESULTS

Found (41) clinical trials

Talazoparib For Neoadjuvant Treatment Of Germline Brca1/2 Mutation Patients With Early Triple-negative Breast Cancer

TALAZOPARIB (PARP INHIBITOR) FOR NEOADJUVANT TREATMENT OF GERMLINE BRCA1/2 MUTATION PATIENTS WITH EARLY TRIPLE NEGATIVE BREAST CANCER. THIS IS A MONOTHERAPY TREATMENT FOR 24 WKS FOLLOWED BY SURGERY TO EVALUATE PATHOLOGICAL COMPLETE RESPONSE.

Phase

1.04 miles

Learn More »

The objective of the study is to evaluate the safety and efficacy of ONZETRA Xsail (AVP-825) compared to placebo in the acute treatment of migraine in adolescent patients, 12 through 17 years of age.

Phase

1.04 miles

Learn More »

This is a Phase 3, dose-escalation study designed to evaluate the safety and efficacy of both elagolix 150 mg QD and elagolix 200 mg BID plus E2/NETA (1 mg/0.5 mg) QD over 24 months in the management of endometriosis with associated moderate to severe pain in premenopausal women.

Phase

1.04 miles

Learn More »

The purpose of the Stroke AF study is to compare the incidence of atrial fibrillation (AF) through 12 months between continuous cardiac rhythm monitoring with the Reveal LINQ™ Insertable Cardiac Monitor (ICM) (continuous monitoring arm) and standard of care (SoC) medical treatment (control arm) in subjects with a recent ischemic ...

Phase N/A

1.04 miles

Learn More »

To evaluate whether or not prolonged suppressive oral antiviral treatment with valacyclovir reduces complications of HZO including new or worsening dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis and/or postherpetic neuralgia compared to placebo.

Phase

1.04 miles

Learn More »

The purpose of the study is to evaluate changes in key clinical outcome measures (eg, motor, respiratory, fatigue) in adult subjects with late-onset Pompe disease (LOPD) receiving standard-of-care enzyme replacement therapy (alglucosidase alfa; ERT).

Phase N/A

1.04 miles

Learn More »

The primary purpose of this study is to determine whether treatment with the Cobra PzF stent with 14 day Dual Anti-Platelet Therapy (DAPT) has a better safety profile compared to standard FDA approved Drug Eluting Stent plus 6-Month Dual Anti-Platelet Therapy in patients undergoing coronary intervention who also require oral ...

Phase N/A

1.04 miles

Learn More »

The objective of this study is to evaluate the effectiveness of MicroVention Carotid Stent System used in conjunction with the Nanoparasol embolic protection system for the treatment of carotid artery stenosis in patients with elevated risk for adverse events following carotid endarterectomy.  The stent is a self-expanding implant with a ...

Phase N/A

1.04 miles

Learn More »

This research study is investigating a medical device called the ZOLL Short-term use Wearable Defibrillator (“SWD 1000”).  A defibrillator is a device used to control an abnormal heart beat by applying an electric current, also known as "shocking", to the chest wall or heart. We are asking you to take ...

Phase N/A

1.04 miles

Learn More »

The objective of the HeartFlow ADVANCE Registry is to evaluate utility, clinical outcomes and resource utilization of FFRCT-guided evaluation in clinically stable, symptomatic patients with coronary artery disease (CAD) in order to further inform patients, health care providers, and other stakeholders about which technologies are most effective and efficient in ...

Phase N/A

1.04 miles

Learn More »